Suppr超能文献

有乳腺癌家族史女性中与乳腺磁共振成像使用相关的因素。

Factors associated with breast MRI use among women with a family history of breast cancer.

作者信息

White Mary C, Soman Ashwini, Weinberg Clarice R, Rodriguez Juan L, Sabatino Susan A, Peipins Lucy A, DeRoo Lisa, Nichols Hazel B, Hodgson M Elizabeth, Sandler Dale P

机构信息

Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Epidemiology and Applied Research Branch, Atlanta, GA, USA.

Information Systems, Northrop Grumman Corporation, Atlanta, GA, USA.

出版信息

Breast J. 2018 Sep;24(5):764-771. doi: 10.1111/tbj.13063. Epub 2018 May 20.

Abstract

Although annual breast magnetic resonance imaging (MRI) is recommended for women at high risk for breast cancer as an adjunct to screening mammography, breast MRI use remains low. We examined factors associated with breast MRI use in a cohort of women with a family history of breast cancer but no personal cancer history. Study participants came from the Sister Study cohort, a nationwide, prospective study of women with at least 1 sister who had been diagnosed with breast cancer but who themselves had not ever had breast cancer (n = 17 894). Participants were surveyed on breast cancer beliefs, cancer worry, breast MRI use, provider communication, and genetic counseling and testing. Logistic regression was used to assess factors associated with having a breast MRI overall and for those at high risk. Breast MRI was reported by 16.1% and was more common among younger women and those with higher incomes. After adjustment for demographics, ever use of breast MRI was associated with actual and perceived risk. Odds ratios (OR) were 12.29 (95% CI, 8.85-17.06), 2.48 (95% CI, 2.27-2.71), and 2.50 (95% CI, 2.09-2.99) for positive BRCA1/2 test, lifetime breast cancer risk ≥ 20%, and being told by a health care provider of higher risk, respectively. Women who believed they had much higher risk than others or had higher level of worry were twice as likely to have had breast MRI; OR = 2.23 (95% CI, 1.82-2.75) and OR = 1.76 (95% CI, 1.52-2.04). Patterns were similar among women at high risk. Breast cancer risk, provider communication, and personal beliefs were determinants of breast MRI use. To support shared decisions about the use of breast MRI, women could benefit from improved understanding of the chances of getting breast cancer and increased quality of provider communications.

摘要

尽管对于乳腺癌高危女性,建议每年进行乳腺磁共振成像(MRI)检查,作为乳腺钼靶筛查的辅助手段,但乳腺MRI的使用比例仍然较低。我们在一组有乳腺癌家族史但无个人癌症病史的女性队列中,研究了与乳腺MRI使用相关的因素。研究参与者来自姐妹研究队列,这是一项针对至少有1名姐妹被诊断为乳腺癌但自身从未患过乳腺癌的女性的全国性前瞻性研究(n = 17894)。对参与者进行了关于乳腺癌信念、癌症担忧、乳腺MRI使用情况、医疗服务提供者沟通以及遗传咨询和检测的调查。采用逻辑回归分析来评估总体上以及高危人群中与进行乳腺MRI检查相关的因素。报告显示,16.1%的人进行了乳腺MRI检查,且在年轻女性和高收入女性中更为常见。在对人口统计学因素进行调整后,曾经使用乳腺MRI检查与实际风险和感知风险相关。BRCA1/2检测呈阳性、终生患乳腺癌风险≥20%以及被医疗服务提供者告知风险较高的女性,其优势比(OR)分别为12.29(95%可信区间,8.85 - 17.06)、2.48(95%可信区间,2.27 - 2.71)和2.50(95%可信区间,2.09 - 2.99)。认为自己比其他人风险高得多或担忧程度较高的女性进行乳腺MRI检查的可能性是其他人的两倍;OR = 2.23(95%可信区间,1.82 - 2.75)和OR = 1.76(95%可信区间,1.52 - 2.04)。高危女性中的情况类似。乳腺癌风险、医疗服务提供者沟通以及个人信念是乳腺MRI使用的决定因素。为了支持关于乳腺MRI使用的共同决策,女性可能会从更好地了解患乳腺癌的几率以及提高医疗服务提供者沟通质量中受益。

相似文献

1
Factors associated with breast MRI use among women with a family history of breast cancer.
Breast J. 2018 Sep;24(5):764-771. doi: 10.1111/tbj.13063. Epub 2018 May 20.
2
Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk.
JAMA Oncol. 2020 Sep 1;6(9):1381-1389. doi: 10.1001/jamaoncol.2020.2922.
9
Mammography screening and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a prospective study.
Breast Cancer Res Treat. 2014 Aug;147(1):113-8. doi: 10.1007/s10549-014-3063-y. Epub 2014 Aug 1.

引用本文的文献

2
Barriers and facilitators to breast cancer screening among high-risk women: a qualitative study.
Breast Cancer Res Treat. 2025 Jan;209(1):61-71. doi: 10.1007/s10549-024-07471-y. Epub 2024 Aug 27.
3
Self-reported barriers to screening breast MRI among women at high risk for breast cancer.
Breast Cancer Res Treat. 2023 Nov;202(2):345-355. doi: 10.1007/s10549-023-07085-w. Epub 2023 Aug 28.
4
Patterns of Screening Mammography and Breast MRI During the COVID-19 Pandemic: A Retrospective, Chart-Review Study.
J Breast Imaging. 2023 Feb 23;5(3):277-286. doi: 10.1093/jbi/wbad006. eCollection 2023 May-Jun.
5
Cone-Beam Breast Computed Tomography: Time for a New Paradigm in Breast Imaging.
J Clin Med. 2021 Oct 31;10(21):5135. doi: 10.3390/jcm10215135.
6
Association of Family History with the Development of Breast Cancer: A Cohort Study of 129,374 Women in KoGES Data.
Int J Environ Res Public Health. 2021 Jun 13;18(12):6409. doi: 10.3390/ijerph18126409.

本文引用的文献

1
Informing Women and Their Physicians about Recommendations for Adjunct Breast MRI Screening: A Cohort Study.
Health Commun. 2018 Apr;33(4):489-495. doi: 10.1080/10410236.2016.1278499. Epub 2017 Feb 3.
3
Risk-benefit profiles of women using tamoxifen for chemoprevention.
J Natl Cancer Inst. 2014 Dec 3;107(1):354. doi: 10.1093/jnci/dju354. Print 2015 Jan.
5
Cognitive and affective influences on perceived risk of ovarian cancer.
Psychooncology. 2015 Mar;24(3):279-86. doi: 10.1002/pon.3593. Epub 2014 Jun 11.
6
Patterns of breast magnetic resonance imaging use in community practice.
JAMA Intern Med. 2014 Jan;174(1):125-32. doi: 10.1001/jamainternmed.2013.11963.
7
Rapid increase in breast magnetic resonance imaging use: trends from 2000 to 2011.
JAMA Intern Med. 2014 Jan;174(1):114-21. doi: 10.1001/jamainternmed.2013.11958.
8
Breast MRI use uncommon among U.S. women.
Cancer Epidemiol Biomarkers Prev. 2013 Jan;22(1):159-66. doi: 10.1158/1055-9965.EPI-12-0967. Epub 2012 Nov 15.
9
Bias in the reporting of family history: implications for clinical care.
J Genet Couns. 2012 Aug;21(4):547-56. doi: 10.1007/s10897-011-9470-x. Epub 2012 Jan 12.
10
MRI for breast cancer screening, diagnosis, and treatment.
Lancet. 2011 Nov 19;378(9805):1804-11. doi: 10.1016/S0140-6736(11)61350-0.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验